FEATURED POST

Tennessee execution: Billy Ray Irick tortured to death, expert says in new filing

Image
Editor's note: Reporter Dave Boucher was one of seven state-required media witnesses at Irick's execution. 
Billy Ray Irick felt searing pain akin to torture before he died in a Tennessee prison in August, but steps taken in carrying out his execution blocked signs of suffering, according to a doctor who reviewed information about the lethal injection.
In new court filings entered late Thursday amidst an ongoing legal challenge of Tennessee’s lethal injection protocol, Dr. David Lubarsky said statements from people who witnessed the execution indicated the controversial drug midazolam failed to ensure Irick could not feel pain during his death.
As a result, the death row inmate “experienced the feeling of choking, drowning in his own fluids, suffocating, being buried alive, and the burning sensation caused by the injection of the potassium chloride,” Lubarsky wrote in the filing.
The document also says the state did not follow its own lethal injection protocol, raising questio…

Scott Dozier case: Hours before execution, judge in pharma company suit halts use of drug

Midazolam
LAS VEGAS -- A Nevada judge is halting the use of a drug in the execution of twice-convicted killer Scott Raymond Dozier hours before he was scheduled to die by a first-of-its-kind lethal injection mixture.

Clark County District Court Judge Elizabeth Gonzalez ordered the delay Wednesday morning in response to a challenge by New Jersey-based drugmaker Alvogen, which says it doesn't want its product, midazolam, used in "botched" executions.

Alvogen's objections were aired at a hearing that unfolded less than 11 hours before Dozier was to be put to death with a three-drug injection never before tried in the U.S. 

The pharmaceutical company urged a judge to block the use of midazolam, saying the state of Nevada obtained the product through "subterfuge" for unapproved purposes. Dozier has insisted he wants to be executed and doesn't care if it's painful. The ruling effectively put the execution on hold.

Todd Bice, an attorney with Alvogen, accused the state of deceptively obtaining the company's drug by having it shipped to a pharmacy in Las Vegas rather than the state prison in Ely. Alvogen sent a letter to state officials in April telling them it opposes the use of its products in executions, particularly the sedative midazolam, Bice said. 

The judge ruled that based on that letter, Alvogen had a reasonable probability of winning its lawsuit, and she issued the temporary restraining order against the use of the drug. Gonzalez set a hearing in the case for Sept. 10.  

Alvogen said in a statement that it was pleased with the ruling and will continue to work through the legal system to ensure its products are not used in executions.

A second pharmaceutical company, Sandoz, also raised objections Wednesday to the use of one of its drugs - the muscle-paralyzing substance cisatracurium - in the execution. But the company did not immediately ask to formally join Alvogen's lawsuit.

A third company, Pfizer, last year demanded Nevada return the third drug intended for use in the execution, the powerful opioid fentanyl. But the state has refused. Fentanyl, which has been blamed for deadly overdoses across the country, has not been used before in an execution.

Jordan T. Smith, an assistant Nevada solicitor general, countered at Wednesday's hearing that Nevada didn't put up a "smokescreen" or do anything wrong in getting the drugs. He said drugs ordered by the state prison system are regularly shipped to Las Vegas.

"This whole action is just PR damage control," Smith said of Alvogen.

The order is the first time a drug company has successfully sued to halt an execution in the U.S. involving one of its drugs. Pharmaceutical companies have resisted the use of their drugs in executions for 10 years, citing both legal and ethical concerns. The legal challenge filed by Alvogen is only the second of its kind in the U.S, said Robert Dunham, executive director of the Death Penalty Information Center in Washington. The previous challenge, filed last year by a different company in Arkansas, was unsuccessful in halting that execution.

Fentanyl
Alvogen's midazolam was substituted in May for Nevada's expired stock of diazepam, commonly known as Valium. Nevada's new execution protocol also calls for the use of fentanyl to slow the inmate's breathing and cisatracurium to stop his breathing.

Dozier, who attempted suicide in the past, has said he prefers execution to life behind bars.

"Life in prison isn't a life," the 47-year-old Army veteran and methamphetamine user and dealer told the Las Vegas Review-Journal recently. In court hearings and letters, he said there is a limit to how much artwork and exercise a person can do in prison.

Dozier was sentenced to death in 2007 for robbing, killing and dismembering 22-year-old Jeremiah Miller at a Las Vegas motel in 2002. Miller had come to Nevada to buy ingredients to make meth. His decapitated torso was found in a suitcase.

In 2005, Dozier was sentenced to 22 years in prison for shooting to death another drug-trade associate, 26-year-old Jasen Greene, whose body was found in 2002 in a shallow grave outside Phoenix. A witness testified Dozier used a sledgehammer to break Greene's limbs so the corpse would fit in a plastic storage container.

Though Dozier dropped attempts to save his own life, he allowed federal public defenders to challenge the execution protocol. They argued that the untried three-drug combination would be less humane than putting down a pet.

Midazolam has been used with inconsistent results in states including Alabama, Arkansas, Arizona, Florida and Ohio. In 2014, an inmate in Ohio and another one in Arizona were left gasping and snorting before they died in what death penalty foes called botched executions.

Nevada's last execution was in 2006.

Source: CBS News, The Associated Press, July, 2018  2:59 PM EDT


Judge halts tonight's Nevada execution, but Supreme Court could hear appeal today


Scott Dozier
A Nevada judge effectively put the execution of a two-time killer on hold Wednesday after a pharmaceutical company objected to the use of one of its drugs to put someone to death.

Clark County District Judge Elizabeth Gonzalez disallowed the use of the drug in a ruling that came down less than nine hours before Scott Raymond Dozier, 47, was to be executed with a three-chemical injection never before tried in the U.S.

The Nevada Supreme Court could hear an appeal Wednesday afternoon of the judge's ruling to halt the use of a drug in the execution of a twice-convicted killer.

Supreme Court spokesman Michael Sommermeyer says that some of the seven justices are in Chicago for a Nevada State Bar Association meeting, but that the court could meet by teleconference.

The state of Nevada had not yet appealed by midday. The state said it would explore whether it could appeal to the Nevada Supreme Court.

Nevada state prisons spokeswoman Brooke Santina had no immediate comment.

The delay is likely to be at least 60 days, according to a tweet from the ACLU of Nevada.

If the ruling sticks, Alvogen would become the first drugmaker to successfully sue to halt an execution.

New Jersey-based Alvogen had urged the judge to block the use of its sedative midazolam, saying that the state illegally obtained the product through "subterfuge" and intended to use it for unapproved purposes. The pharmaceutical company raised concerns that the drug could lead to a botched execution, citing cases that seemingly went awry elsewhere around the country.

Todd Bice, an attorney with Alvogen, accused the state of deceptively obtaining the company's drug by having it shipped to a pharmacy in Las Vegas rather than the state prison in Ely. He said Alvogen had sent a letter to state officials in April telling them it opposes the use of its products in executions, particularly midazolam.

The judge ruled that based on that letter, Alvogen had a reasonable probability of winning its lawsuit, and she issued the temporary restraining order against the use of the drug. Gonzalez set a hearing in the case for Sept. 10.

Alvogen said in a statement that it was pleased with the ruling and will continue to work through the legal system to ensure its products are not used in executions.

A second pharmaceutical company, Sandoz, also raised objections at Wednesday's hearing to the use of one of its drugs — the muscle-paralyzing substance cisatracurium — in the execution. But the company did not immediately ask to formally join Alvogen's lawsuit.

A third company, Pfizer, last year demanded Nevada return the third drug intended for use in the execution, the powerful opioid fentanyl. But the state refused. Fentanyl, which has been blamed for deadly overdoses across the country, has not been used before in an execution.

Jordan T. Smith, an assistant Nevada solicitor general, countered at Wednesday's hearing that Nevada didn't put up a "smokescreen" or do anything wrong in getting the drugs. He said drugs ordered by the state prison system are regularly shipped to Las Vegas.

"This whole action is just PR damage control," Smith said of Alvogen.

Pharmaceutical companies have resisted the use of their drugs in executions for 10 years, citing both legal and ethical concerns. However, the legal challenge filed by Alvogen is only the second of its kind in the U.S, said Robert Dunham, executive director of the Death Penalty Information Center in Washington. The previous challenge, filed last year by a different company in Arkansas, was ultimately unsuccessful in stopping that execution.

Alvogen's midazolam was substituted in May for Nevada's expired stock of diazepam, commonly known as Valium. The drug is intended to render the inmate unconscious. Nevada's new execution protocol also calls for the use of fentanyl to slow the inmate's breathing and cisatracurium to stop his breathing.

Bice said that Alvogen does not take a position on the death penalty itself but opposes the use of the drug in a way that is fundamentally contrary to the drug's purpose — saving and improving patients' lives.

In court papers, Alvogen also cited the risk of a botched execution, citing instances in Alabama, Arizona and Oklahoma in the past few years in which inmates were left gasping or snorting, appeared to regain consciousness or took an unusually long time to die.

Dozier, who attempted suicide in the past, has said he prefers execution to life behind bars.

And for the past year, Dozier has been fighting to secure his own execution. He described life on death row as “not an acceptable life.”

Source: Reno Gazette Journal, July 11, 2018


⚑ | Report an error, an omission, a typo; suggest a story or a new angle to an existing story; submit a piece, a comment; recommend a resource; contact the webmaster, contact us: deathpenaltynews@gmail.com.


Opposed to Capital Punishment? Help us keep this blog up and running! DONATE!



"One is absolutely sickened, not by the crimes that the wicked have committed,
but by the punishments that the good have inflicted." -- Oscar Wilde

Most Viewed (Last 7 Days)

Idaho Department Of Correction Can Keep Lethal Injection Drugs Secret, Judge Says

Double Dose: 2 executions in Texas next week

Florida: Trial for man accused of throwing daughter from Pinellas County bridge delayed

Virginia: Convicted killer, already facing death penalty, admits slaying 2 girls in Illinois in 2005

Belarus: the Last Refuge for the Death Penalty in Europe

Malaysian death sentences commuted for 3 Mexican brothers

'No Time To Sleep' to depict last day of death penalty inmate

The Machinery of Death Is Back on the Docket

20 Minutes to Death: Record of the Last Execution in France

Death penalty sought for SC man accused of ‘brutally’ molesting, killing toddler